Archives
|
Entry
|
Blogger
|
Date
|
Location
|
|
ZymoGenetics, King Pharma Brawl Over Drugs to Control Surgical Bleeding
|
Luke Timmerman |
11/09/09 |
Seattle
|
|
ZymoGenetics’ Former Medical Boss Leads Rival Startup, ProFibrix, With Drug For Bleeding
|
Luke Timmerman |
10/26/09 |
Seattle
|
|
ZymoGenetics Plays Hardball, Targeted Genetics’ Legacy, Omeros Preps for Fall IPO, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
08/27/09 |
Seattle
|
|
ZymoGenetics, Citing Two Patient Deaths, Builds Up Ammunition for Case Against Rival
|
Luke Timmerman |
08/20/09 |
Seattle
|
|
ZymoGenetics Plays Hardball, Asks FDA to Pull Competing Drug Off Market Because of Safety
|
Luke Timmerman |
08/20/09 |
Seattle
|
|
AVI Bolts to Seattle, OncoGenex Escapes Dendreon’s Shadow, Buddhists Helping Biotech, & More Seattle-Area Life Sciences News
|
Luke Timmerman |
08/06/09 |
Seattle
|
|
Zymo Gets $6M in Q2 Recothrom Sales
|
Luke Timmerman |
08/03/09 |
Seattle
|
|
ZymoGenetics Drug Sales Still Slumping After Full Year on Market
|
Luke Timmerman |
05/05/09 |
Seattle
|
|
ZymoGenetics Cuts One-Third of Workforce To Hold Onto Cash
|
Luke Timmerman |
04/29/09 |
Seattle
|
|
ZymoGenetics Sales Chief Exits
|
Luke Timmerman |
02/04/09 |
Seattle
|
|
ZymoGenetics’ New Boss Sees Parallels to Dark Days at Immunex
|
Luke Timmerman |
01/05/09 |
Seattle
|
|
Blood News: A Quick Rundown of Headlines From the American Society of Hematology
|
Luke Timmerman |
12/09/08 |
National
|
|
ZymoGenetics Drug For Surgical Bleeding Demonstrates Safety in Trial
|
Luke Timmerman |
12/08/08 |
Seattle
|
|
ZymoGenetics Cash Gets Lean, Recothrom Sales Still Slow
|
Luke Timmerman |
11/04/08 |
Seattle
|
|
ZymoGenetics’ Kidney Cancer Drug, Taken with Nexavar, Shrinks Tumors in Relapsed Patients
|
Luke Timmerman |
10/22/08 |
Seattle
|
|
Seattle Genetics’ Medical Point Man, Tom Reynolds, Aims to Capitalize on Hodgkin’s Drug
|
Luke Timmerman |
09/08/08 |
Seattle
|
|
ZymoGenetics, Bayer Drug Vying for European Regulatory Approval
|
Luke Timmerman |
09/02/08 |
Seattle
|
|
ZymoGenetics Sells Land for $11.5 Million
|
Luke Timmerman |
08/29/08 |
Seattle
|
|
ZymoGenetics Drug Getting Off to Slow Start in Marketplace
|
Luke Timmerman |
08/06/08 |
Seattle
|
|
ZymoGenetics Receives $100 Million Commitment From Deerfield
|
Luke Timmerman |
06/30/08 |
Seattle
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.
© 2007-2009, Xconomy, Inc.
XCONOMY is a registered service mark of Xconomy, Inc.
All rights reserved.
Site designed by
Matthew Bouchard, produced by
Andrew Koyfman,
and powered by WordPress.
